These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36865788)

  • 1. Impact of VALID Act implementation on mass spectrometry-based clinical proteomic laboratory developed tests.
    Lin Y; Thomas SN
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():30-34. PubMed ID: 36865788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative tandem mass spectrometry in the clinical laboratory: Regulation and opportunity for validation of laboratory developed tests.
    Stone JA; van der Gugten JG
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():82-90. PubMed ID: 36937811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric laboratory developed tests filling the gaps for children in crisis.
    Bunch DR
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():80-81. PubMed ID: 36909287
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the loss of Laboratory Developed Mass Spectrometry testing at a major academic medical center.
    Geno KA; Cervinski MA
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():63-66. PubMed ID: 36846026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities.
    Offit K; Sharkey CM; Green D; Wu X; Trottier M; Hamilton JG; Walsh MF; Dandiker S; Belhadj S; Lipkin SM; Sugrañes TA; Caggana M; Stadler ZK
    J Clin Oncol; 2023 Jan; 41(1):11-21. PubMed ID: 35944238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. College of american pathologists proposal for the oversight of laboratory-developed tests.
    Vance GH
    Arch Pathol Lab Med; 2011 Nov; 135(11):1432-5. PubMed ID: 22032569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High-Level Overview of the Regulations Surrounding a Clinical Laboratory and Upcoming Regulatory Challenges for Laboratory Developed Tests.
    Graden KC; Bennett SA; Delaney SR; Gill HE; Willrich MAV
    Lab Med; 2021 Jul; 52(4):315-328. PubMed ID: 33283241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory-developed test regulation and the immunocompromised patient: uncertainty ahead.
    Clark AE; Levy J; Lee FM
    Curr Opin Infect Dis; 2020 Aug; 33(4):304-311. PubMed ID: 32657967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation]).
    Spitzenberger F; Patel J; Gebuhr I; Kruttwig K; Safi A; Meisel C
    Ther Innov Regul Sci; 2022 Jan; 56(1):47-64. PubMed ID: 34291407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Laboratory-Developed Tests.
    Genzen JR
    Am J Clin Pathol; 2019 Jul; 152(2):122-131. PubMed ID: 31242284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Food and Drug Administration's Jurisdiction Over Laboratory-Developed Tests and Divisions Between Food, Drug, and Cosmetic Act-Regulated and Clinical Laboratory Improvement Amendments of 1988-Regulated Activities.
    Thompson BM; Scott BI; Boiani JA
    Clin Lab Med; 2016 Sep; 36(3):575-85. PubMed ID: 27514469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing.
    Menlyadiev M; Suhandynata RT; Lund K; Kelner MJ; Fitzgerald RL
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():105-113. PubMed ID: 37025609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory-Developed Tests: A Legislative and Regulatory Review.
    Genzen JR; Mohlman JS; Lynch JL; Squires MW; Weiss RL
    Clin Chem; 2017 Oct; 63(10):1575-1584. PubMed ID: 28687634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing.
    French D
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():13-19. PubMed ID: 36756146
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens.
    Lund K; Menlyadiev M; Lee K; Kelner MJ; Fitzgerald RL; Suhandynata RT
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():91-98. PubMed ID: 36937812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
    Schniedewind B; Meyer EJ; Christians U
    Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.
    Kim AS; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Moncur JT
    JAMA Oncol; 2018 Jun; 4(6):838-841. PubMed ID: 29242895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease.
    Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
    J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():107-117. PubMed ID: 35602306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and winding regulatory road for laboratory-developed tests.
    Weiss RL
    Am J Clin Pathol; 2012 Jul; 138(1):20-6. PubMed ID: 22706853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.